Navigation Links
Launch of New Educational Campaign, Spread the Word - NOT the Flu!, Aims to Highlight Importance of Influenza Vaccination
Date:9/26/2007

- Coalition of forces join to launch educational program to help students

make a difference in influenza prevention - Detailed curriculum teaches students about influenza and empowers them to

be ambassadors of health at home and in their community

CAMBRIDGE, Mass., Sept. 26 /PRNewswire-FirstCall/ -- Spread the Word - NOT the Flu! is a new educational program designed to teach students and their families about the seriousness of influenza and the importance of receiving an annual vaccination. Through this program, children can make a difference by helping their families and communities learn about influenza prevention.

Spread the Word - NOT the Flu! is a national program launched today by Novartis Vaccines, together with Families Fighting Flu, Inc, a non-profit organization that provides support to all families affected by childhood influenza-related deaths, and Weekly Reader Corporation Custom Publishing. The program aims to help communities prepare for the 2007-2008 influenza season and reduce the burden associated with annual influenza infections.

"Influenza does not discriminate, so it is imperative that people of all ages are aware of the steps one can take to prevent the spread of this disease," said Theodore F. Tsai MD, MPH, FIDSA Medical Director, North America Novartis Vaccines. "This is why we are proud to sponsor this educational program specifically geared toward teaching students about influenza and encouraging them to share their knowledge with their family to help protect their community this influenza season."

Spread the Word - NOT the Flu! consists of a detailed curriculum that teaches students about influenza facts, such as how the virus spreads, what its symptoms are, who is at risk for potentially serious complications and how to help prevent the spread of influenza. This program can be accessed at http://www.SpreadTheWordNotTh
'/>"/>

SOURCE Novartis Vaccines and Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Glaxo launches pills to help smokers quit in 7-12 weeks
3. Action Plan Against Drug Deaths Launched
4. New Health Scheme Launched In India’s Biha
5. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
6. Dr Reddy’s Laboratories launches Hyalosy
7. Sun Pharma to launch chiral version of omeprazole soon
8. Asmanex Twisthaler launched by Schering-Plough for treatment of asthma
9. New initiative launched to fight malaria by repelling mosquitoes
10. Clarithromycin tablets to be launched in India soon
11. Guide for physicians launched to help them identify alcohol disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...gies (LCT) Limited has published evidence outlinin...e islet cells and insulin production in a human pa...ansplant. The scientific paper published in the ...journal Xenotransplantation outlines how LCT has d...
...gh source of nutrition for many people around the ...aten in several forms, it is the key ingredient fo.... With Easter just round the corner an animal righ...nch a campaign on Wednesday urging people not to e...
...ed several genetic risk factors leading to prostat...s the first real evidence of the genetic basis of ...e Keck School of Medicine at the University of Sou... the researchers of the study. "It gives us the ...
... their obsession for that ‘bronzed and beautiful’ ...nd, opine researchers. // According to a report p... of Public Health, the increases in people going i...ming. This is particularly so when considered in ...
Other Medicine News:Health News:Transplanted Pig Cells in Human Produce Insulin 2Health News:Transplanted Pig Cells in Human Produce Insulin 3Health News:Sultans of Suntans Warned 2
(Date:9/4/2008)...zing Patient Identification for Targeted Therapies... Treatment HUNTINGTON BEACH, Calif., and AMSTER... a world leader in molecular cancer diagnostics,t... diagnostic test that,allows physicians to quantit...e estrogen receptor (ER), progesterone receptor (P...
(Date:9/3/2008)..., Sept. 3 /- Simcere,Pharma...er and supplier of,branded generic pharmaceuticals...ech product Endu (also known as Endostar) in China...linical study., At the request of the SFDA, Simce...validate the safety and therapeutic efficacy of En...
(Date:9/3/2008)...ium and GENEVA, Sept. 3 /- Artelis SA... CHO based monoclonal antibody,production with the...ams,per liter. This record level was accomplished ...) a high-performance stable Selexis CHO,production...cientists at,Selexis SA using their proprietary Se...
(Date:9/3/2008)...s Operations, Updates Zingo Launch Progress and Ad... Conference Call Today at 11:30 am...wire-FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) ...operations to focus on commercial and late-stage p... a specialty pharmaceutical pain management,compan...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Core People Partners to Expand Services 15673 1Core People Partners to Expand Services 15673 2Sutter Opens Countys First Non Hospital Based Nuclear Imaging Option 15668 1Sutter Opens Countys First Non Hospital Based Nuclear Imaging Option 15668 2Sutter Opens Countys First Non Hospital Based Nuclear Imaging Option 15668 3Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 1Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 2Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 3Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 4Scientists solve mystery of polyketide drug formation 15662 1Scientists solve mystery of polyketide drug formation 15662 2
...and CAPTURE 2 Findings Suggest Improved Outcomes i...h 26, 2007 /PRNewswire-FirstCall/ --,Positive 30-d...rotid stenting can be performed with positive resu...erience in real-world,(non-clinical trial) setting... surgery. Interim results from the first 1,500,pat...
...Program to be Presented at Keystone Scientific Mee.../PRNewswire-FirstCall/ -- Rigel today announced th...rology, will be presenting,on the company,s effort... patients with the Human Immunodeficiency Virus (H... Columbia on March,27th and 29th. Dr. Jenkins will...
Other Medicine Technology:Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 2Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 3Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 4Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 2Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 3
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products: